12099 Berlin, de
+49 (30) 75019-134
aap Implantate AG reports Q1 trauma sales growth of 46%, fueled by LOQTEQ® growth of more than 180%
On a like for like basis, the continued operations (aap Implantate AG without EMCM B.V.) show, without project sales, a sales growth to EUR 6.1 million, a 32% increase compared to the corresponding sales of EUR 4.6 million in the first quarter of 2013. The trauma sales for the same period increased by 46% to EUR 2.1 million; driven especially by LOQTEQ® sales growth of more than 180%. The sales growth without project sales of more than 30% in the first quarter for the Biomaterials business (Biomaterials, bone cements and cementing devices) sets a good trend for the financial year 2014.
Bruke Seyoum Alemu, COO, comments: "First quarter sales, especially those for trauma, represent a strong start of 2014. The growth of the LOQTEQ® portfolio is a confirmation of the positive market feedback of our LOQTEQ® technology."
The divestment of the contract manufacturing subsidiary EMCM underlines the initiated strategic orientation to become a focused Trauma company. aap reports it has received the 2nd instalment of EUR 6 million for the sales of its shares in EMCM; a total of EUR 12 million has been received so far. The last payment of EUR 6 million is scheduled to be paid before April 30th.
Next to the dynamic Trauma business, in combination with the issued silver coating patent in the USA in February and the development in the magnesium technology, the company shows progress in building a broad based platform that can address the fundamental challenges in trauma healthcare, enabling new standards for infection prevention and resorbable implants.
Publication of the interim report for the first quarter of 2014 is scheduled for May 15, 2014.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.